Clinipace Blog

Following Clinipace’s Boosting Enrollment in Oncology Trials webcast, we wanted to share some of our thoughts on the need for protocol simplification especially in early phase oncology trials, as well as field some related attendee questions.

Despite its rich pipeline, cardiovascular device innovation is slowing.  In this webcast, you’ll gain insight into the cardiovascular device research pipeline and approval trends.  In addition, we’ll outline five key steps you need to take to be successful in your global CV medical device trials. 

Within this series of posts, Mike Trudnak, Daryl Porter, and I want to first describe the common language associated with clouds and potential benefits to organizations that use them.  We will then expose a newer framework that changes the discussion from the traditional public/private/hybrid clouds to another model of describing cloud formations.  We will end the series with a deeper look at what cloud formation best illustrates Clinipace Worldwide as a cloud provider.

Drug resistance is reaching crisis proportions in the US and globally, challenging sponsors to continuously develop new approaches to the treatment of infections.  The incidence of infection with multi-drug resistant (MDR) gram-negative bacteria is on the rise, particularly among patients in healthcare settings. 

The Triangle Business Journal and accounting giant BDO have honored Clinipace with one of its inaugural Life Sciences Awards.  The awards recognize both individuals and research organizations that are breaking ground in this field.

I wanted to tackle an attendee question submitted during the One-Stop Shopping for Clinical Trial Management: The Value Proposition of a dCRO Paradigm webcast.  The question asks: What do you mean by data queries in real time? What is the difference with a traditional EDC where queries are issued also online?

Join our panel of experts for an interactive presentation to learn more about the brewing controversy around whether a US-style, centralized approval process will ultimately help or hurt the medical device industry in the EU.

On April 30^th, we held our most popular live webcast to-date, “Trends and Considerations in Global Infectious Disease Drug Development.” Attendees learned about current trends in global clinical development of infectious disease therapies

Following the recent One-Stop Shopping for Clinical Trial Management: The Value Proposition of a dCRO Paradigm webcast, I collaborated with Lisa Jamba (Service Line Architecture Specialist) and Mike Trudnak (Executive Director, IT) to answer attendee questions.  

I recently co-presented a webcast on increasing study efficiency through the use of technology with my colleague, Crista Casey. We received several questions related to maintaining compliance for the preparation and storage of Study Documents while managing trials via a digital eClinical platform.

Following the “Best Practices for Boosting Enrollment in Oncology Trials” webcast  - I wanted to explore a topic that received a lot of interest and feedback – the use of social media and technology for patient recruitment.

It was a pleasure to team with my industry colleague, Chris Mackay, Project Director, Early Phase Pharma, University of Kansas Cancer Center, for a recent webcast on “Best Practices for Boosting Enrollment in Oncology Trials”. We received a lot of great feedback during and after the presentation, so we’re working on a series of blog posts to address many of the questions received.

Today, I was quoted widely in a story In-PharmaTechnologist.com published titled US API Imports for Clinical Trials Now Require Effective IND, Expert Says. The story came as a result of my recent “Outsourcing Clinical Supplies Manufacturing: Navigating US Import Laws” webcast.  

Our next webcast tackles how we can come together to help meet the continuing, ever-changing threat from infectious disease. Learn about the emerging trends in infectious disease drug development, advanced technologies, and related regulatory considerations that can affect outcomes of this global threat.

I led a webcast on March 27^th entitled “Outsourcing Clinical Supplies Manufacturing: Navigating US Import Laws.” During the webcast, we asked attendees several polling questions and I wanted to share the results from one that looks at their experiences to date with Port of Entry import restrictions.